Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLVE-LDL-C
NCT06865885Phase 4Recruiting
- Sponsor
- University of California, San Diego
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypercholesterolemia comparing Standard of Care with Inclisiran Arm (2 arms). Primary endpoint: Change of LDL-Cholesterol at 12 months. Started Apr 2025; status: recruiting.
02
Drugs
inclisiran
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT06865885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06865885.